{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:13:43Z","timestamp":1790540023907,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s10557-005-3350-2","type":"journal-article","created":{"date-parts":[[2005,9,27]],"date-time":"2005-09-27T05:45:31Z","timestamp":1127799931000},"page":"301-306","source":"Crossref","is-referenced-by-count":77,"title":["Combination Therapy with Metolazone and Loop Diuretics in Outpatients with Refractory Heart Failure: An Observational Study and Review of the Literature"],"prefix":"10.1007","volume":"19","author":[{"given":"Jens","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Galatius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Rossen","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,20]]},"reference":[{"key":"3350_CR1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/hrt.71.2.146","volume":"71","author":"KS Channer","year":"1994","unstructured":"Channer KS, McLean KA, Lawson-Matthew P, Richardson M. Combination diuretic treatment in severe heart failure: A randomised controlled trial. Br Heart J 1994;71:146\u2013150.","journal-title":"Br Heart J"},{"key":"3350_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00003088-199630030-00004","volume":"30","author":"DA Sica","year":"1996","unstructured":"Sica DA, Gehr TW. Diuretic combinations in refractory oedema states: Pharmacokinetic-pharmacodynamic relationships. Clin Pharmacokinet 1996;30:229\u2013249.","journal-title":"Clin Pharmacokinet"},{"key":"3350_CR3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1053\/euhj.2001.2783","volume":"22","author":"WJ Remme","year":"2001","unstructured":"Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527\u20131560.","journal-title":"Eur Heart J"},{"key":"3350_CR4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","volume":"26","author":"K Swedberg","year":"2005","unstructured":"Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115\u20131140.","journal-title":"Eur Heart J"},{"key":"3350_CR5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1054\/jcaf.2003.25","volume":"9","author":"P Faggiano","year":"2003","unstructured":"Faggiano P, Opasich C, Tavazzi L, et al. Prescription patterns of diuretics in chronic heart failure: A contemporary background as a clue to their role in treatment. J Card Fail 2003;9:210\u2013218.","journal-title":"J Card Fail"},{"key":"3350_CR6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","volume":"24","author":"M Komajda","year":"2003","unstructured":"Komajda M, Follath F, Swedberg K, et al. The EuroHeart Failure Survey programme: A survey on the quality of care among patients with heart failure in Europe. Part 2: Treatment. Eur Heart J 2003;24:464\u2013474.","journal-title":"Eur Heart J"},{"key":"3350_CR7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/clc.4960231211","volume":"23","author":"TM Ramahi","year":"2000","unstructured":"Ramahi TM, Longo MD, Rohlfs K, Sheynberg N. Effect of heart failure program on cardiovascular drug utilization and dosage in patients with chronic heart failure. Clin Cardiol 2000;23:909\u2013914.","journal-title":"Clin Cardiol"},{"key":"3350_CR8","first-page":"787","volume":"22","author":"I Grosskopf","year":"1986","unstructured":"Grosskopf I, Rabinovitz M, Rosenfeld JB. Combination of furosemide and metolazone in the treatment of severe congestive heart failure. Isr J Med Sci 1986;22:787\u2013790.","journal-title":"Isr J Med Sci"},{"key":"3350_CR9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/cpt1974162322","volume":"16","author":"WJ Tilstone","year":"1974","unstructured":"Tilstone WJ, Dargie H, Dargie EN, Morgan HG, Kennedy AC. Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure. Clin Pharmacol Ther 1974;16:322\u2013329.","journal-title":"Clin Pharmacol Ther"},{"key":"3350_CR10","first-page":"276","volume":"29","author":"ON Hinsvark","year":"1970","unstructured":"Hinsvark ON, Cohen AI. The study of metolazone, a new diuretic, in human body fluids using thin layer separation, liquid chromatographic measurements and14C-counting techniques. Fed Proc 1970;29:276 (Abstract).","journal-title":"Fed Proc"},{"key":"3350_CR11","first-page":"276","volume":"29","author":"KN Modi","year":"1970","unstructured":"Modi KN, Iberra L, Nodine JH. Human pharmacokinetic studies with14C-Zaroxolyn, a new type of diuretic agent. Fed Proc 1970;29:276 (Abstract).","journal-title":"Fed Proc"},{"key":"3350_CR12","first-page":"381A","volume":"35","author":"DA Sica","year":"1987","unstructured":"Sica DA, Brater D, Centor R, Davis J, Fakhry I. Metolazone-probenecid interaction in man. Clin Res 1987;35:381A (Abstract).","journal-title":"Clin Res"},{"key":"3350_CR13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ki.1972.24","volume":"1","author":"ST Steinmuller","year":"1972","unstructured":"Steinmuller ST, Puschett JB. Effects of metolazone in man: Comparison with chlorothiazide. Kidney Int 1972;1:169\u2013181.","journal-title":"Kidney Int"},{"key":"3350_CR14","first-page":"6","volume":"180","author":"WN Suki","year":"1972","unstructured":"Suki WN, Dawoud F, Eknoyan G, Martinez-Maldonado M. Effects of metolazone on renal function in normal man. J Pharmacol Exp Ther 1972;180:6\u201312.","journal-title":"J Pharmacol Exp Ther"},{"key":"3350_CR15","first-page":"457","volume":"132","author":"W Herbinger","year":"1982","unstructured":"Herbinger W. Diuretika in der Therapie der chronischen Herzinsuffizienz. Wien Med Wochenschr 1982;132:457\u2013464.","journal-title":"Wien Med Wochenschr"},{"key":"3350_CR16","first-page":"134","volume":"4","author":"AW Asscher","year":"1974","unstructured":"Asscher AW. Treatment of frusemide resistant oedema with metolazone. Clin Trials J 1974;4:134\u2013139.","journal-title":"Clin Trials J"},{"key":"3350_CR17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/pgmj.47.554.789","volume":"47","author":"RF Gunstone","year":"1971","unstructured":"Gunstone RF, Wing AJ, Shani HG, Njemo D, Sabuka EM. Clinical experience with metolazone in fifty-two African patients: Synergy with frusemide. Postgrad Med J 1971;47:789\u2013793.","journal-title":"Postgrad Med J"},{"key":"3350_CR18","first-page":"656","volume":"21","author":"M Epstein","year":"1977","unstructured":"Epstein M, Lepp BA, Hoffman DS, Levinson R. Potentiation of furosemide by metolazone in refractory edema. Curr Ther Res 1977;21:656\u2013667.","journal-title":"Curr Ther Res"},{"key":"3350_CR19","first-page":"275A","volume":"25","author":"MJ Reichgott","year":"1977","unstructured":"Reichgott MJ, Ram CVS. Synergism between metolazone and loop-diuretics. Clin Res 1977;25:275A (Abstract).","journal-title":"Clin Res"},{"key":"3350_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0002-8703(75)90041-1","volume":"89","author":"B Sigurd","year":"1975","unstructured":"Sigurd B, Olesen KH, Wennevold A. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide. Am Heart J 1975;89:163\u2013170.","journal-title":"Am Heart J"},{"key":"3350_CR21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2362.1985.tb00179.x","volume":"15","author":"C Marone","year":"1985","unstructured":"Marone C, Muggli F, Lahn W, Frey FJ. Pharmacokinetic and pharmacodynamic interaction between furosemide and metolazone in man. Eur J Clin Invest 1985;15:253\u2013257.","journal-title":"Eur J Clin Invest"},{"key":"3350_CR22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(89)92243-5","volume":"1","author":"DJ Aravot","year":"1989","unstructured":"Aravot DJ, Banner NR, Musumeci F, et al. Oral metolazone plus frusemide for home therapy in patients with refractory heart failure. Lancet 1989;1:727\u2013728.","journal-title":"Lancet"},{"key":"3350_CR23","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/bmj.282.6279.1873-a","volume":"282","author":"JM Allen","year":"1981","unstructured":"Allen JM, Hind CR, McMichael HB. Synergistic action of metolazone with \u201cloop\u201d diuretics. BMJ 1981;282:1873.","journal-title":"BMJ"},{"key":"3350_CR24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/hrt.82.3.397a","volume":"82","author":"AJ Broadley","year":"1999","unstructured":"Broadley AJ, Marshall AJ. Self administration of metolzaone reduces readmissions with decompensated congestive cardiac failure. Heart 1999;82:397\u2013398.","journal-title":"Heart"},{"key":"3350_CR25","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/bmj.282.6274.1432","volume":"282","author":"RR Ghose","year":"1981","unstructured":"Ghose RR, Gupta SK. Synergistic action of metolazone with \u201cloop\u201d diuretics. BMJ 1981;282:1432\u20131433.","journal-title":"BMJ"},{"key":"3350_CR26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0140-6736(90)91091-N","volume":"335","author":"N Kr\u00f6ger","year":"1990","unstructured":"Kr\u00f6ger N, Szuba J, Buhl C, Pompecki R, Frenzel H. Metolazone for severe dilated cardiomyopathy refractory to conventional therapy. Lancet 1990;335:1031\u20131032.","journal-title":"Lancet"},{"key":"3350_CR27","first-page":"305","volume":"86","author":"N Kr\u00f6ger","year":"1991","unstructured":"Kr\u00f6ger N, Szuba J, Frenzel H. Metolazone in der Behandlung fortgeschrittener therapieresistenter dilatativer Kardiomyopathie. Med Klin 1991;86:305\u2013308, 332.","journal-title":"Med Klin"},{"key":"3350_CR28","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1067\/mhj.2002.123841","volume":"144","author":"S Galatius","year":"2002","unstructured":"Galatius S, Gustafsson F, Nielsen PH, Atar D, Hildebrandt PR. An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. Am Heart J 2002;144:E2.","journal-title":"Am Heart J"},{"key":"3350_CR29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0140-6736(89)90048-2","volume":"1","author":"AT Hattersley","year":"1989","unstructured":"Hattersley AT, Langley S, Thompson JR, Blackwood RA. Home intravenous diuretic therapy for patient with refractory heart failure. Lancet 1989;1:446.","journal-title":"Lancet"},{"key":"3350_CR30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0002-9149(89)90320-2","volume":"63","author":"LW Stevenson","year":"1989","unstructured":"Stevenson LW, Dracup KA, Tillisch JH. Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. Am J Cardiol 1989;63:461\u2013464.","journal-title":"Am J Cardiol"},{"key":"3350_CR31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00007611-197804000-00011","volume":"71","author":"WD Black","year":"1978","unstructured":"Black WD, Shiner PT, Roman J. Severe electrolyte disturbances associated with metolazone and furosemide. South Med J 1978;71:380\u20131, 385.","journal-title":"South Med J"},{"key":"3350_CR32","first-page":"255","volume":"64","author":"B Keogh","year":"1971","unstructured":"Keogh B, Carmody M, Malone D, O'Dwyer WF. Clinical and biochemical evaluation of a new diuretic agent (Metolazone). J Ir Med Assoc 1971;64:255\u2013260.","journal-title":"J Ir Med Assoc"},{"key":"3350_CR33","first-page":"396","volume":"14","author":"ML Gelfand","year":"1974","unstructured":"Gelfand ML, Cortega A, Lieu K. The use of metolazone in the treatment of congestive heart failure. J Clin Pharmacol 1974;14:396\u2013397.","journal-title":"J Clin Pharmacol"},{"key":"3350_CR34","first-page":"641","volume":"18","author":"BA Levey","year":"1975","unstructured":"Levey BA, Palmer RF. Biochemical and clinical effects of metolazone in congestive heart failure. Curr Ther Res Clin Exp 1975;18:641\u2013651.","journal-title":"Curr Ther Res Clin Exp"},{"key":"3350_CR35","first-page":"147","volume":"23","author":"UK Sheth","year":"1977","unstructured":"Sheth UK, Mehta JM, Paul T, Sumati N, Sanghvi B. Clinical experience with metolazone\u2014a new diuretic\u2014in cases of edema and ascites due to hepatic cirrhosis, congestive cardiac failure and malnutrition. J Postgrad Med 1977;23:147\u2013155.","journal-title":"J Postgrad Med"},{"key":"3350_CR36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/pgmj.56.652.121","volume":"56","author":"RS Bonser","year":"1980","unstructured":"Bonser RS, Ghose RR. Demeclocycline therapy for resistant oedema in advanced cardiac failure. Postgrad Med J 1980;56:121\u2013123.","journal-title":"Postgrad Med J"},{"key":"3350_CR37","first-page":"1825","volume":"110","author":"J Furrer","year":"1980","unstructured":"Furrer J, Hess OM, Kuhlmann U, Satz N, Siegenthaler W. Furosemid und Metolazon: Eine hochwirksame Diuretikakombination. Schweiz Med Wochenschr 1980;110: 1825\u20131829.","journal-title":"Schweiz Med Wochenschr"},{"key":"3350_CR38","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/bmj.283.6291.618-b","volume":"283","author":"JM Bamford","year":"1981","unstructured":"Bamford JM. Synergistic action of metolazone with \u201cloop\u201d diuretics. BMJ 1981;283:618.","journal-title":"BMJ"},{"key":"3350_CR39","first-page":"435","volume":"111","author":"E Arosio","year":"1984","unstructured":"Arosio E, Pancera P, Apolloni E, Covi G, Lechi A. Valutazione clinica del metolazone nelle sindromi edemigene. Clin Ter 1984;111:435\u2013442.","journal-title":"Clin Ter"},{"key":"3350_CR40","first-page":"727","volume":"1","author":"JS Friedland","year":"1989","unstructured":"Friedland JS, Ledingham JGG. Oral metolazone plus frusemide for home therapy in patients with refractory heart failure. Lancet 1989;1:727\u2013728.","journal-title":"Lancet"},{"key":"3350_CR41","first-page":"775","volume":"8","author":"Kirancumar","year":"1989","unstructured":"Kirancumar, Loureiro PA, Correia JM. Metolazone in the treatment of refractory heart insufficiency. Experience of 10 cases. Rev Port Cardiol 1989;8:775\u2013778 (Abstract).","journal-title":"Rev Port Cardiol"},{"key":"3350_CR42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0140-6736(90)90148-X","volume":"335","author":"A Kiyingi","year":"1990","unstructured":"Kiyingi A, Field MJ, Pawsey CC, Yiannikas J, Lawrence JR, Arter WJ. Metolazone in treatment of severe refractory congestive cardiac failure. Lancet 1990;335:29\u201331.","journal-title":"Lancet"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-005-3350-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-005-3350-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-005-3350-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:27:54Z","timestamp":1559237274000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-005-3350-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["3350"],"URL":"https:\/\/doi.org\/10.1007\/s10557-005-3350-2","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}